Health Care & Life Sciences » Biotechnology | Addex Therapeutics Ltd.

Addex Therapeutics Ltd. | Balance Sheet

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,913.40
1,979.60
2,633.60
1,416.40
2,590.50
41,670.20
Total Accounts Receivable
811.50
91.50
132.10
220.70
303.90
273
Other Current Assets
176.10
67.90
17.10
21.40
158.90
207.40
Total Current Assets
3,901.00
2,139.00
2,782.80
1,658.50
3,053.30
42,150.60
Net Property, Plant & Equipment
179.50
44.70
31.80
17.30
2.80
8.90
Total Investments and Advances
-
1,558.70
75.10
7.10
7.10
54.40
Intangible Assets
52.60
13.20
-
-
-
-
Other Assets
1,746.50
243.70
-
-
-
-
Total Assets
5,879.70
3,999.20
2,889.70
1,682.90
3,063.20
42,213.80
Accounts Payable
605.80
647.30
170.90
669.70
383.20
Other Current Liabilities
1,757.40
861.70
858.90
580.20
1,093.60
Total Current Liabilities
2,363.20
1,509.00
1,029.80
1,249.90
1,476.80
Provision for Risks & Charges
490.40
144.50
195.70
214.40
243.90
Total Liabilities
2,853.70
1,653.50
1,225.50
1,464.30
1,720.70
Common Equity (Total)
3,026.00
2,345.70
1,664.20
218.60
1,342.50
Total Shareholders' Equity
3,026.00
2,345.70
1,664.20
218.60
1,342.50
Total Equity
3,026.00
2,345.70
1,664.20
218.60
1,342.50
Liabilities & Shareholders' Equity
5,879.70
3,999.20
2,889.70
1,682.90
3,063.20

About Addex Therapeutics

View Profile
Address
12, Chemin des Aulx
Geneva Geneve (Geneva) 1228
Switzerland
Employees -
Website http://www.addextherapeutics.com
Updated 07/08/2019
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.